new glp-1 agonist How medications are transforming diabetes and weight loss treatment Glucagon-like peptide-1 receptor agonists and
Description
Interestingly, this raises important points in regard to the need to hold GLP-1 RAs prior to concurrent EGD and colonoscopy procedures and the number of days needed to hold these agents, if necessary
Are you a candidate?
Ozempic has become a buzzword in weight loss and type 2 diabetes management
While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives
A reminder that their story doesnt start in Hollywood
